Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation
Roger Hudson, Justine Renard, Christopher Norris, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 44, pp. 8762-8777
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 194
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martı́nez, Amaia Iriondo‐DeHond, Francesca Borrelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 143
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
Brooks Johnson, Natalie Strand, John Raynak, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 530-530
Open Access | Times Cited: 1
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Mina G. Nashed, Daniel B. Hardy, Steven R. Laviolette
Frontiers in Psychiatry (2021) Vol. 11
Open Access | Times Cited: 54
Potency testing of cannabinoids by liquid and supercritical fluid chromatography: Where we are, what we need
Simona Felletti, Chiara De Luca, Alessandro Buratti, et al.
Journal of Chromatography A (2021) Vol. 1651, pp. 462304-462304
Closed Access | Times Cited: 31
Therapeutic potential of cannabinoids in combination cancer therapy
Pratibha Malhotra, Ilaria Casari, Marco Falasca
Advances in Biological Regulation (2021) Vol. 79, pp. 100774-100774
Closed Access | Times Cited: 27
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
Saoirse E. O’Sullivan, Carl W. Stevenson, Steven R. Laviolette
Cannabis and Cannabinoid Research (2020) Vol. 6, Iss. 1, pp. 7-18
Open Access | Times Cited: 32
Investigating Cannabidiol’s Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review
Jes Sebastian Denis Völker, I. Micluția, Ramona-Cristina Vinași
European Journal of Pharmacology (2024) Vol. 979, pp. 176821-176821
Closed Access | Times Cited: 3
Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons
Ahmed Hasbi, Bertha K. Madras, Jack Bergman, et al.
iScience (2019) Vol. 23, Iss. 1, pp. 100794-100794
Open Access | Times Cited: 27
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Graziella dos Reis Rosa Franco, Scott D. Smid, Cláudio Viegas
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 449-464
Open Access | Times Cited: 27
The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol
Brandon Gunasekera, Cathy Davies, Rocı́o Martı́n-Santos, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 636-645
Closed Access | Times Cited: 26
Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies
Bradley J. Vivace, Allyson N. Sanders, Steven D. Glassman, et al.
Journal of Orthopaedic Surgery and Research (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Cannabinoids, reward processing, and psychosis
Brandon Gunasekera, Kelly Diederen, Sagnik Bhattacharyya
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1157-1177
Open Access | Times Cited: 19
Prenatal tetrahydrocannabinol and cannabidiol exposure produce sex-specific pathophysiological phenotypes in the adolescent prefrontal cortex and hippocampus
Marieka V. DeVuono, Mina G. Nashed, Mohammed H. Sarikahya, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106588-106588
Open Access | Times Cited: 2
Investigating endocannabinoid system and subjective responses to exercise in cancer patients: Rationale and future research directions
Abha Gourshettiwar, Judith Lacey, Shelley Kay, et al.
JSAMS Plus (2024) Vol. 4, pp. 100073-100073
Open Access | Times Cited: 2
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
Bilal Jawed, Jessica Elisabetta Esposito, Riccardo Pulcini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12453-12453
Open Access | Times Cited: 2
Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models
Bryan W. Jenkins, Jibran Y. Khokhar
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 17
A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History
Volker Berl, Yasmin L. Hurd, Bruce H. Lipshutz, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 6, pp. 777-789
Open Access | Times Cited: 12
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 19-30
Open Access | Times Cited: 6
THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways
Hanna J. Szkudlarek, Mar Rodríguez-Ruiz, Roger Hudson, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110029-110029
Closed Access | Times Cited: 17
The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats
Ilne L. Barnard, Timothy J. Onofrychuk, Thaísa Meira Sandini, et al.
Neurobiology of Learning and Memory (2022) Vol. 192, pp. 107624-107624
Closed Access | Times Cited: 10
Cognitive Alterations in Addictive Disorders: A Translational Approach
Ani Gasparyan, Daniel Sánchez, Francisco Navarrete, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1796-1796
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top